NOEL; Romain

Patent Applications and Registrations

Patent applications and USPTO patent grants for NOEL; Romain.The latest application filed is for "injectable solution at ph 7 comprising at least a basal insulin which pi is comprised between 5.8 and 8.5 and a copolyamino acid bearing carboxylate charges and hydrophobic radicals".

Company Profile

8.6.12

NOEL; Romain - Villeurbanne FR
Noel; Romain - Trevou-Treguinec FR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Injectable Solution At Ph 7 Comprising At Least A Basal Insulin Which Pi Is Comprised Between 5.8 And 8.5 And A Copolyamino Acid Bearing Carboxylate Charges And Hydrophobic Radicals App 20220040099 - DURACHER; David ; et al.	2022-02-10
Compositions In The Form Of An Injectable Aqueous Solution Comprising Amylin, An Amylin Agonist Receptor Or An Amylin Analogue And A Co-polyamino Acid App 20210401943 - CHAN; You-Ping ; et al.	2021-12-30
Compositions In The Form Of An Injectable Aqueous Solution Comprising Human Glucagon And A Co-polyamino Acid App 20210386830 - CHAN; You-ping ; et al.	2021-12-16
Compositions in the form of an injectable aqueous solution comprising human glucagon and a co-polyamino acid Grant 11,191,812 - Chan , et al. December 7, 2	2021-12-07
Compositions in the form of an injectable aqueous solution comprising amylin, an amylin receptor agonist or an amylin analog and a co-polyamino acid Grant 11,173,109 - Chan , et al. November 16, 2	2021-11-16
Compositions in the form of an injectable aqueous solution comprising amylin, an amylin agonist receptor or an amylin analogue and a co-polyamino acid Grant 11,129,877 - Chan , et al. September 28, 2	2021-09-28
Compositions in the form of an injectable aqueous solution comprising human glucagon and a co-polyamino acid Grant 10,987,426 - Chan , et al. April 27, 2	2021-04-27
Injectable Ph 7 Solution Comprising At Least One Basal Insulin Having A Pi From 5.8 To 8.5 And A Co-polyamino Acid Bearing Carboxylate Charges And Hydrophobic Radicals App 20200306379 - CHAN; You-Ping ; et al.	2020-10-01
Injectable Solution At Ph 7 Comprising At Least One Basal Insulin The Pi Of Which Is From 5.8 To 8.5 And A Co-polyamino Acid Bea App 20190388515 - GEISSLER; Alexandre ; et al.	2019-12-26
Compositions In The Form Of An Injectable Aqueous Solution Comprising Amylin, An Amylin Agonist Receptor Or An Amylin Analogue A App 20190328842 - CHAN; You-Ping ; et al.	2019-10-31
Compositions In The Form Of An Injectable Aqueous Solution Comprising Human Glucagon And A Co-polyamino Acid App 20190275109 - CHAN; You-Ping ; et al.	2019-09-12
Injectable Solution At Ph 7 Comprising At Least One Basal Insulin Wherein The Pi Is Comprised Form 5.8 To 8.5 And A Co-polyamino App 20190275115 - CHAN; You-Ping ; et al.	2019-09-12
Copositions in the form of an injectable aqueous solution comprising amylin, an amylin receptor agonist or an amylin analog and App 20190274954 - Chan; You-Ping ; et al.	2019-09-12
Compositions Sous Forme D'une Solution Aqueuse Injectable Comprenant Du Glucagon Humain Et Un Co-polyaminoacide App 20190275156 - CHAN; You-Ping ; et al.	2019-09-12
2,3-dihydroquinazolin-4(1H)-one derivatives for use in the treatment of viral infections Grant 9,675,615 - Gillet , et al. June 13, 2	2017-06-13
Compounds having a protective activity against toxins with intracellular activity Grant 9,540,356 - Gillet , et al. January 10, 2	2017-01-10
New Compounds Having A Protective Activity Against Toxins With Intracellular Activity App 20150291568 - Gillet; Daniel ; et al.	2015-10-15
2,3-dihydroquinazolin-4(1h)-one Derivatives For Use In The Treatment Of Viral Infections App 20150250788 - Gillet; Daniel ; et al.	2015-09-10

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.